|1.||Hoskin, David W: 8 articles (10/2013 - 04/2005)|
|2.||Jenssen, Håvard: 4 articles (03/2012 - 05/2003)|
|3.||Mader, Jamie S: 4 articles (06/2010 - 04/2005)|
|4.||Furlong, Suzanne J: 3 articles (06/2010 - 05/2006)|
|5.||Rekdal, Øystein: 3 articles (08/2006 - 09/2002)|
|6.||Superti, Fabiana: 3 articles (05/2004 - 04/2003)|
|7.||Antonini, Giovanni: 3 articles (05/2004 - 04/2003)|
|8.||Lohner, Karl: 2 articles (11/2015 - 10/2014)|
|9.||Zweytick, Dagmar: 2 articles (11/2015 - 10/2014)|
|10.||Rinner, Beate: 2 articles (11/2015 - 10/2014)|
10/01/2014 - "In this study derivatives of a short cationic peptide derived from the human host defense peptide lactoferricin were optimized in their selective toxicity towards cancer cells. "
09/01/2002 - "In this study the antitumor activities exerted by LFB, LfcinB and murine lactoferricin (LfcinM) on murine tumor cell lines and experimental tumors were investigated. "
10/30/2009 - "Bovine lactoferricin (LfcinB) is a cationic antimicrobial peptide with potent cytotoxic activity against cancer cells. "
03/01/2008 - "Bovine lactoferricin (LfcinB) is a cationic antimicrobial peptide that selectively induces apoptosis in several different types of human cancer cells. "
04/01/2005 - "Bovine lactoferricin (LfcinB) is a cationic, amphipathic peptide that is cytotoxic for human and rodent cancer cells. "
03/01/2012 - "Lactoferricin however showed promising results as a therapeutic agent and delayed both disease onset by 3days as well as reducing the viral load almost 15-fold when given as a single dose 24h post-infection. "
01/01/2014 - "Investigation of anti-infection mechanism of lactoferricin and splunc-1."
03/01/2012 - "When admixed with virus prior to inoculation, lactoferricin inhibited disease development and significantly reduced the viral load in a genital model of HSV-2 infection in mice. "
09/01/2007 - "This is the first time that lactoferricin was demonstrated to have an inhibitory effect on HPV infection and the antiviral activity differed depending on size, charge and structures of the lactoferricin."
09/01/2007 - "Among the other derivatives, the human lactoferricin (hLfcin) 1-49 showed some antiviral activity against HPV PsV infection while bLfcin 17-42 inhibited only HPV-5 PsV infection in one of the cell lines. "
|3.||Melanoma (Melanoma, Malignant)
10/01/2014 - "Killing of melanoma cells and their metastases by human lactoferricin derivatives requires interaction with the cancer marker phosphatidylserine."
11/01/2015 - "In this study we report on characteristic features of human lactoferricin (hLFcin) derivatives which facilitate specific killing of cancer cells of melanoma, glioblastoma and rhabdomyosarcoma compared with non-specific derivatives and the synthetic peptide RW-AH. "
01/01/1998 - "The effect of a bovine milk protein, lactoferrin (bLf), and a pepsin-generated peptide of bLf, lactoferricin (Lfcin-B), on inhibition of tumor metastasis produced by highly metastatic murine tumor cells, B16-BL6 melanoma and L5178Y-ML25 lymphoma cells, was examined in experimental and spontaneous metastasis models using syngeneic mice. "
02/01/1997 - "We investigated the effect of a bovine milk protein, lactoferrin (LF-B), and a pepsin-generated peptide of LF-B, lactoferricin (Lfcin-B), on inhibition of tumor metastasis produced by highly metastatic murine tumor cells, B16-BL6 melanoma and L5178Y-ML25 lymphoma cells, using experimental and spontaneous metastasis models in syngeneic mice. "
06/01/2010 - "The objectives of this study were to determine whether a synergistic effect could be obtained in vitro between bovine lactoferricin (B-LFcin) and antibiotics against Pseudomonas aeruginosa and Staphylococcus aureus isolates from ocular infections, and to evaluate the use of B-LFcin as an adjunct to the antibiotic treatment of corneal infection in vivo. "
|4.||Anti-Bacterial Agents (Antibiotics)
|6.||Pepsin A (Pepsin)
|7.||Milk Proteins (Milk Protein)
|9.||Serine Proteases (Serine Protease)
|1.||Heterologous Transplantation (Xenotransplantation)